IMPURITIES AVAILABLE FOR 'Everolimus'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Everolimus. Everolimus is an oral mTOR (mammalian target of rapamycin) inhibitor used as an anticancer and immunosuppressive agent. It is commonly prescribed for the treatment of advanced kidney cancer, breast cancer, pancreatic neuroendocrine tumors, and tuberous sclerosis-related tumors. Everolimus works by blocking mTOR signaling, which reduces cell growth, proliferation, and angiogenesis in cancer cells. In transplant medicine, it helps prevent organ rejection by suppressing immune system activity. It is usually administered orally in tablet form and has a long half-life, allowing once-daily dosing. Common side effects include mouth ulcers, infections, fatigue, rash, diarrhea, and reduced blood cell counts. Regular monitoring of kidney function, blood glucose, and lipid levels is recommended during therapy to manage potential adverse effects. Buy high quality Everolimus from Omsynth Lifesciences.